News Lundbeck epilepsy injection approved in US New carbamazepine formulation when oral dosing not feasible.
News GW could be next big pharma takeover target UK firm has hired bankers to deal with approaches - press reports.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
